Source: Annual Congress 2003 - Diagnosis of tuberculosis and laboratory aspects: genetics and immunobiology
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
D. Vincenti, S. Carrara, F. Palmieri, P. De Mori, L. Pucillo, N. Petrosillo, O. Armignacco, E. Girardi, M. Amicosante, D. Goletti (Rome, Viterbo, Italy). Identification of ESAT-6 Epitopes for the Immunodiagnosis of Active Tuberculosis. Eur Respir J 2003; 22: Suppl. 45, 2150

Member's Comments

No comment yet.

Related content which might interest you: Recombinant Tuberculosis Allergen in Detecting Latent Tuberculosis Infection in Adults Source: International Congress 2018 – Tuberculosis transmission and screening strategies Year: 2018 Tuberculosis Antigen Stimulated CXCR3 Ligand Assay for the Diagnosis of Tuberculous Lymphadenitis Source: International Congress 2019 – Tuberculosis: diagnosis Year: 2019 Prevalence of Latent Infection with Mycobacterium Tuberculosis in Interstitial Lung Diseases Using Interferon Gamma Release Assay Source: International Congress 2017 – Lung fibrosis: basic science Year: 2017 Use of the Recombinant Tuberculosis Allergen in the Early Diagnosis of Tuberculosis in Paediatric Patients Source: International Congress 2018 – Groups who are susceptible to tuberculosis: children, pregnant women and elderly people Year: 2018 Mycobacterium tuberculosis Cording in Alveolar Macrophages of Tuberculosis Patients and Mycobacterial Virulence Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections Year: 2017 Transcriptional Signature Identifies Phenotypic Heterogeneity of Human Tuberculosis Infection Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools Year: 2018 Clinical evaluation of glycopeptidolipid core antigen IgA antibodies for serodiagnosis of mycobacterium avium complex disease Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology Year: 2015 Vitamin D and LL-37 Levels In Childhood Tuberculosis Disease and Latent Tuberculosis Infection Source: International Congress 2019 – Paediatric respiratory infections around the world: Tuberculosis, pneumonia and others Year: 2019 Posttreatment Lymphopenia Is Associated With an Increased Risk of Redeveloping Nontuberculous Mycobacterial Lung Disease in Patients With Mycobacterium avium Complex Lung Disease Source: Virtual Congress 2021 – Advances in diagnosis, treatment and clinical management of nontuberculous mycobacterial disease Year: 2021 Usefulness of serum glycopeptidolipid core immunoglobulin A antibody in mycobacterium avium complex infection Source: International Congress 2014 – Tuberculosis: diagnosis Year: 2014 Pulmonary Tuberculosis and latent Tuberculosis Source: ERS Skills Course 2016 Year: 2016 Clinical evaluation of glycopeptidolipid core antigen IgA antibodies for serodiagnosis of mycobacterium avium complex pulmonary disease Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management Year: 2013 Serodiagnosis of mycobacterium avium-complex pulmonary disease using anti-glycopeptidolipid core antigen IgA antibody Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 LATE-BREAKING ABSTRACT: Intracellular ESAT-6: a new biomarker of mycobacterium tuberculosis infection? Source: Annual Congress 2013 –Diagnostic features of tuberculosis II Year: 2013 Local immunodiagnosis of tuberculosis Source: Annual Congress 2009 - Novel diagnostics in tuberculosis Year: 2009 Species-specific Interferon-Gamma Release Assay for the diagnosis of Mycobacterium abscessus complex infection in Cystic Fibrosis patients. Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities Year: 2021 Diagnostic utility of Primary  Line Probe Assay in Extrapulmonary Tuberculosis Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020 Characterization of the Immune Response in Clinical Sepsis To Identify Potential Therapeutic Targets Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection Year: 2020